Envista Holdings Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2022

Quarterly Results, Trends, Rankings, Statistics

Envista Holdings Corporation's ability to collect accounts receivable sequentially worsen to 6.25, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Average collection period, for Envista Holdings's accounts receivable remained unchanged at 58 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 194 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1702, from overall ranking in the third quarter 2023 at 2054.

What is Receivable Turnover Ratio?
What is Envista Holdings Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

NVST Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 29 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	3.56 %	6.35 %	11.37 %	17.28 %	18.56 %
Y / Y Revenue Change	-2.3 %	0.03 %	2.57 %	-0.67 %	46.1 %
Receivable Turnover Ratio (TTM)	6.25	6.34	6.44	6.58	6.85
NVST's Total Ranking	# 1702	# 2054	# 2386	# 641	# 1830
Average receivable collection period	58	58	57	56	53
Seq. Receivable Change	-2.3 %	0.46 %	3.33 %	2.11 %	0.33 %
Seq. Revenue Change	2.27 %	-4.7 %	5.61 %	-5.08 %	4.71 %

New: More NVST's historic Receivables Turnover Ratios >>

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 69
Healthcare Sector	# 195
Overall Market	# 1702

Receivable Turnover Ratio Statistics
High	Average	Low
8.07	6.29	2.31
(Oct 01 2021)		(Jul 03 2020)

NVST Company Profile • Back to NVST Efficiency Comparisons • Compare NVST Receivables Turnover Ratio to its Competitors

Financial Statements
Envista Holdings's Accounts Receivable	$ 408 Millions	Visit NVST's Balance sheet
Envista Holdings's Sales TTM	$ 2,567 Millions	Visit NVST's Income Statement
Where are NVST's Sales coming from?		Visit NVST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NVST's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for NVST's Competitors
Receivables Turnover Ratio for NVST's Suppliers
Accounts Receivables Turnover Ratio for NVST's Customers

You may also want to know
NVST's Growth Rates	NVST's Roa	NVST's Inventory Turnover Ratio	NVST's Dividend Comparisons
NVST's Profitability Ratios	NVST's Roi	NVST's Asset Turnover Ratio	NVST's Dividend Growth
NVST's Valuation Ratios	NVST's Roe	NVST's Financial Strength Ratios	NVST's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Halozyme Therapeutics Inc	17.02	$ 829.253 Millions	$ 48.721 Millions
Qhslab Inc	16.93	$ 1.409 Millions	$ 0.083 Millions
Recursion Pharmaceuticals Inc	15.69	$ 44.575 Millions	$ 2.842 Millions
Owens and Minor inc	15.24	$ 10,333.161 Millions	$ 677.813 Millions
Milestone Scientific Inc	15.03	$ 9.793 Millions	$ 0.651 Millions
Neuroone Medical Technologies Corporation	14.87	$ 2.816 Millions	$ 0.189 Millions
Chemed Corporation	14.52	$ 2,264.417 Millions	$ 155.918 Millions
Icu Medical Inc	14.46	$ 2,259.126 Millions	$ 156.262 Millions
Lftd Partners Inc	14.38	$ 51.611 Millions	$ 3.588 Millions
Patterson Companies Inc	14.11	$ 6,565.239 Millions	$ 465.318 Millions
Corcept Therapeutics Inc	13.70	$ 482.375 Millions	$ 35.215 Millions
Theralink Technologies Inc	13.67	$ 0.511 Millions	$ 0.037 Millions
Precipio inc	13.43	$ 15.197 Millions	$ 1.132 Millions
Protalix Biotherapeutics inc	13.39	$ 65.494 Millions	$ 4.890 Millions
Exact Sciences Corporation	13.25	$ 2,532.479 Millions	$ 191.179 Millions
Lifeloc Technologies Inc	13.20	$ 9.330 Millions	$ 0.707 Millions
Utah Medical Products Inc	12.39	$ 50.658 Millions	$ 4.088 Millions
Teladoc Health Inc	12.18	$ 2,602.415 Millions	$ 213.613 Millions
Caribou Biosciences Inc	12.12	$ 34.477 Millions	$ 2.844 Millions
Zomedica Corp	12.01	$ 24.318 Millions	$ 2.025 Millions
Siga Technologies Inc	11.78	$ 139.917 Millions	$ 11.881 Millions
Thermogenesis Holdings Inc	11.73	$ 8.931 Millions	$ 0.762 Millions
Sunshine Biopharma Inc	11.49	$ 24.093 Millions	$ 2.097 Millions
Integrated Biopharma Inc	11.42	$ 48.833 Millions	$ 4.275 Millions
Option Care Health Inc	11.09	$ 4,302.223 Millions	$ 388.081 Millions
National Research Corporation	11.05	$ 148.580 Millions	$ 13.445 Millions
National Healthcare Corp	10.98	$ 1,141.544 Millions	$ 104.011 Millions
Revance Therapeutics Inc	10.95	$ 234.040 Millions	$ 21.377 Millions
Biontech Se	10.68	$ 4,277.280 Millions	$ 400.624 Millions
Arrowhead Pharmaceuticals Inc	10.29	$ 181.740 Millions	$ 17.670 Millions

Date modified: 2024-02-16T09:33:39+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com